Business ❯ Finance ❯ Stock Market ❯ Stock Performance

S&P 500

Vertex’s IgA Nephropathy Drug Hits Phase 3 Goals, FDA Filing Slated for March

The company plans to use a priority review voucher to pursue a roughly six‑month decision from the FDA.

Lumentum Leads Rally as S&P 500 Adds Coherent, EchoStar and Vertiv

Carvana Soars to Record Highs as S&P 500 Addition Triggers Index-Buying Scramble

Markets Hold Gains as Fed Cut Odds Near 90% Ahead of PCE Report

SanDisk Joins S&P 500 After Breakout Year

BitMine’s Ether Bet Shows $4 Billion Paper Loss as BMNR Slides to Key Support

Sensex, Nifty Edge Higher After Early Slide as Consolidation Persists

Renaissance Large Cap Growth Trails Benchmarks in Q3 as AppLovin Leads, Gartner and Fiserv Weigh

AI Rally Pushes U.S. Stocks to New Records as Shutdown Stalls Key Data

Trump’s 25% Tariffs Weigh on Indian Stocks, Trigger Asia-Pacific Sell-Off

Trade Desk to Join S&P 500 Following Synopsys’s $35 B Ansys Acquisition

Datadog Shares Surge as S&P 500 Inclusion Set for July 9

Robinhood Excluded From June S&P 500 Rebalance Despite Doubling in Value